You are here:
Healthcare Brands — Pharma & Cosmetics Portfolio
Last Updated:February 25, 2026
About This Investor
JP-B-33
Geographic and deal conditions are important for this mandate: Asia. Minority investment Majority investment 100% acquisition Sales of over 5 billion. They are looking for companies to sell that own brands in pharmaceuticals, cosmetics, health foods, nutritional drinks, etc. In India and Bangladesh, we are looking for companies to partner with as distributors. They are…
Healthcare (OTC / Consumer Health)
Asia
Strategic Expansion
$13.1M - $130.8M
Minority / Majority / 100% | Revenue ≥ USD 32.7M
Request Full Investor Profile
Similar Investors
JP-B-510
Budget guidance is $6.54M – $65.4M. From Japan, they are
Logistics & Transportation
ASEAN, Thailand, Vietnam
Strategic Synergy
$6.54M - $65.4M
Minority possible | Majority / 100% | Revenue ≥ USD 19.6M
JP-B-672
Current mandate: Priority theme: Greenfield projects: Renewable energy projects, construction
Renewable Energy (EPC)
ASEAN, India
Diversification
$3.27M - $32.7M
Minority
JP-B-22
They are currently building a shortlist and welcome relevant introductions.
Healthcare Services
Indonesia, Malaysia, Philippines, Thailand, Vietnam
Strategic Expansion
$13.1M - $65.4M
Majority | Revenue ≥ USD 13.1M | 100% (future target)